1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Sulfonamides Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Intestinal Absorption 1.2.3 Intestinal Tract Difficult to Absorb 1.2.4 External Use 1.3 Market by Application 1.3.1 Global Sulfonamides Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Systemic Infection 1.3.3 Intestinal Infection 1.3.4 Burn Infection 1.3.5 Other Infections 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Sulfonamides Market Perspective (2016-2027) 2.2 Sulfonamides Growth Trends by Regions 2.2.1 Sulfonamides Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Sulfonamides Historic Market Share by Regions (2016-2021) 2.2.3 Sulfonamides Forecasted Market Size by Regions (2022-2027) 2.3 Sulfonamides Industry Dynamic 2.3.1 Sulfonamides Market Trends 2.3.2 Sulfonamides Market Drivers 2.3.3 Sulfonamides Market Challenges 2.3.4 Sulfonamides Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Sulfonamides Players by Revenue 3.1.1 Global Top Sulfonamides Players by Revenue (2016-2021) 3.1.2 Global Sulfonamides Revenue Market Share by Players (2016-2021) 3.2 Global Sulfonamides Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Sulfonamides Revenue 3.4 Global Sulfonamides Market Concentration Ratio 3.4.1 Global Sulfonamides Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Sulfonamides Revenue in 2020 3.5 Sulfonamides Key Players Head office and Area Served 3.6 Key Players Sulfonamides Product Solution and Service 3.7 Date of Enter into Sulfonamides Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Sulfonamides Breakdown Data by Type 4.1 Global Sulfonamides Historic Market Size by Type (2016-2021) 4.2 Global Sulfonamides Forecasted Market Size by Type (2022-2027) 5 Sulfonamides Breakdown Data by Application 5.1 Global Sulfonamides Historic Market Size by Application (2016-2021) 5.2 Global Sulfonamides Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Sulfonamides Market Size (2016-2027) 6.2 North America Sulfonamides Market Size by Type 6.2.1 North America Sulfonamides Market Size by Type (2016-2021) 6.2.2 North America Sulfonamides Market Size by Type (2022-2027) 6.2.3 North America Sulfonamides Market Size by Type (2016-2027) 6.3 North America Sulfonamides Market Size by Application 6.3.1 North America Sulfonamides Market Size by Application (2016-2021) 6.3.2 North America Sulfonamides Market Size by Application (2022-2027) 6.3.3 North America Sulfonamides Market Size by Application (2016-2027) 6.4 North America Sulfonamides Market Size by Country 6.4.1 North America Sulfonamides Market Size by Country (2016-2021) 6.4.2 North America Sulfonamides Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Sulfonamides Market Size (2016-2027) 7.2 Europe Sulfonamides Market Size by Type 7.2.1 Europe Sulfonamides Market Size by Type (2016-2021) 7.2.2 Europe Sulfonamides Market Size by Type (2022-2027) 7.2.3 Europe Sulfonamides Market Size by Type (2016-2027) 7.3 Europe Sulfonamides Market Size by Application 7.3.1 Europe Sulfonamides Market Size by Application (2016-2021) 7.3.2 Europe Sulfonamides Market Size by Application (2022-2027) 7.3.3 Europe Sulfonamides Market Size by Application (2016-2027) 7.4 Europe Sulfonamides Market Size by Country 7.4.1 Europe Sulfonamides Market Size by Country (2016-2021) 7.4.2 Europe Sulfonamides Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Sulfonamides Market Size (2016-2027) 8.2 Asia-Pacific Sulfonamides Market Size by Type 8.2.1 Asia-Pacific Sulfonamides Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Sulfonamides Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Sulfonamides Market Size by Type (2016-2027) 8.3 Asia-Pacific Sulfonamides Market Size by Application 8.3.1 Asia-Pacific Sulfonamides Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Sulfonamides Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Sulfonamides Market Size by Application (2016-2027) 8.4 Asia-Pacific Sulfonamides Market Size by Region 8.4.1 Asia-Pacific Sulfonamides Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Sulfonamides Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Sulfonamides Market Size (2016-2027) 9.2 Latin America Sulfonamides Market Size by Type 9.2.1 Latin America Sulfonamides Market Size by Type (2016-2021) 9.2.2 Latin America Sulfonamides Market Size by Type (2022-2027) 9.2.3 Latin America Sulfonamides Market Size by Type (2016-2027) 9.3 Latin America Sulfonamides Market Size by Application 9.3.1 Latin America Sulfonamides Market Size by Application (2016-2021) 9.3.2 Latin America Sulfonamides Market Size by Application (2022-2027) 9.3.3 Latin America Sulfonamides Market Size by Application (2016-2027) 9.4 Latin America Sulfonamides Market Size by Country 9.4.1 Latin America Sulfonamides Market Size by Country (2016-2021) 9.4.2 Latin America Sulfonamides Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Sulfonamides Market Size (2016-2027) 10.2 Middle East & Africa Sulfonamides Market Size by Type 10.2.1 Middle East & Africa Sulfonamides Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Sulfonamides Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Sulfonamides Market Size by Type (2016-2027) 10.3 Middle East & Africa Sulfonamides Market Size by Application 10.3.1 Middle East & Africa Sulfonamides Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Sulfonamides Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Sulfonamides Market Size by Application (2016-2027) 10.4 Middle East & Africa Sulfonamides Market Size by Country 10.4.1 Middle East & Africa Sulfonamides Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Sulfonamides Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Sulfonamides Introduction 11.1.4 Pfizer Revenue in Sulfonamides Business (2016-2021) 11.1.5 Pfizer Recent Development 11.2 Sanofi 11.2.1 Sanofi Company Details 11.2.2 Sanofi Business Overview 11.2.3 Sanofi Sulfonamides Introduction 11.2.4 Sanofi Revenue in Sulfonamides Business (2016-2021) 11.2.5 Sanofi Recent Development 11.3 Roche 11.3.1 Roche Company Details 11.3.2 Roche Business Overview 11.3.3 Roche Sulfonamides Introduction 11.3.4 Roche Revenue in Sulfonamides Business (2016-2021) 11.3.5 Roche Recent Development 11.4 Mylan 11.4.1 Mylan Company Details 11.4.2 Mylan Business Overview 11.4.3 Mylan Sulfonamides Introduction 11.4.4 Mylan Revenue in Sulfonamides Business (2016-2021) 11.4.5 Mylan Recent Development 11.5 Teva 11.5.1 Teva Company Details 11.5.2 Teva Business Overview 11.5.3 Teva Sulfonamides Introduction 11.5.4 Teva Revenue in Sulfonamides Business (2016-2021) 11.5.5 Teva Recent Development 11.6 Bayer 11.6.1 Bayer Company Details 11.6.2 Bayer Business Overview 11.6.3 Bayer Sulfonamides Introduction 11.6.4 Bayer Revenue in Sulfonamides Business (2016-2021) 11.6.5 Bayer Recent Development 11.7 Abbott 11.7.1 Abbott Company Details 11.7.2 Abbott Business Overview 11.7.3 Abbott Sulfonamides Introduction 11.7.4 Abbott Revenue in Sulfonamides Business (2016-2021) 11.7.5 Abbott Recent Development 11.8 GlaxoSmithKline 11.8.1 GlaxoSmithKline Company Details 11.8.2 GlaxoSmithKline Business Overview 11.8.3 GlaxoSmithKline Sulfonamides Introduction 11.8.4 GlaxoSmithKline Revenue in Sulfonamides Business (2016-2021) 11.8.5 GlaxoSmithKline Recent Development 11.9 Boehringer Ingelheim 11.9.1 Boehringer Ingelheim Company Details 11.9.2 Boehringer Ingelheim Business Overview 11.9.3 Boehringer Ingelheim Sulfonamides Introduction 11.9.4 Boehringer Ingelheim Revenue in Sulfonamides Business (2016-2021) 11.9.5 Boehringer Ingelheim Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Sulfonamides Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Intestinal Absorption Table 3. Key Players of Intestinal Tract Difficult to Absorb Table 4. Key Players of External Use Table 5. Global Sulfonamides Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Sulfonamides Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Sulfonamides Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Sulfonamides Market Share by Regions (2016-2021) Table 9. Global Sulfonamides Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Sulfonamides Market Share by Regions (2022-2027) Table 11. Sulfonamides Market Trends Table 12. Sulfonamides Market Drivers Table 13. Sulfonamides Market Challenges Table 14. Sulfonamides Market Restraints Table 15. Global Sulfonamides Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Sulfonamides Market Share by Players (2016-2021) Table 17. Global Top Sulfonamides Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sulfonamides as of 2020) Table 18. Ranking of Global Top Sulfonamides Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Sulfonamides Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Sulfonamides Product Solution and Service Table 22. Date of Enter into Sulfonamides Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Sulfonamides Market Size by Type (2016-2021) (US$ Million) Table 25. Global Sulfonamides Revenue Market Share by Type (2016-2021) Table 26. Global Sulfonamides Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Sulfonamides Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Sulfonamides Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Sulfonamides Revenue Market Share by Application (2016-2021) Table 30. Global Sulfonamides Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Sulfonamides Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Sulfonamides Market Size by Type (2016-2021) (US$ Million) Table 33. North America Sulfonamides Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Sulfonamides Market Size by Application (2016-2021) (US$ Million) Table 35. North America Sulfonamides Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Sulfonamides Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Sulfonamides Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Sulfonamides Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Sulfonamides Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Sulfonamides Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Sulfonamides Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Sulfonamides Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Sulfonamides Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Sulfonamides Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Sulfonamides Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Sulfonamides Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Sulfonamides Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Sulfonamides Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Sulfonamides Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Sulfonamides Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Sulfonamides Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Sulfonamides Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Sulfonamides Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Sulfonamides Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Sulfonamides Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Sulfonamides Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Sulfonamides Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Sulfonamides Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Sulfonamides Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Sulfonamides Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Sulfonamides Market Size by Country (2022-2027) & (US$ Million) Table 62. Pfizer Company Details Table 63. Pfizer Business Overview Table 64. Pfizer Sulfonamides Product Table 65. Pfizer Revenue in Sulfonamides Business (2016-2021) & (US$ Million) Table 66. Pfizer Recent Development Table 67. Sanofi Company Details Table 68. Sanofi Business Overview Table 69. Sanofi Sulfonamides Product Table 70. Sanofi Revenue in Sulfonamides Business (2016-2021) & (US$ Million) Table 71. Sanofi Recent Development Table 72. Roche Company Details Table 73. Roche Business Overview Table 74. Roche Sulfonamides Product Table 75. Roche Revenue in Sulfonamides Business (2016-2021) & (US$ Million) Table 76. Roche Recent Development Table 77. Mylan Company Details Table 78. Mylan Business Overview Table 79. Mylan Sulfonamides Product Table 80. Mylan Revenue in Sulfonamides Business (2016-2021) & (US$ Million) Table 81. Mylan Recent Development Table 82. Teva Company Details Table 83. Teva Business Overview Table 84. Teva Sulfonamides Product Table 85. Teva Revenue in Sulfonamides Business (2016-2021) & (US$ Million) Table 86. Teva Recent Development Table 87. Bayer Company Details Table 88. Bayer Business Overview Table 89. Bayer Sulfonamides Product Table 90. Bayer Revenue in Sulfonamides Business (2016-2021) & (US$ Million) Table 91. Bayer Recent Development Table 92. Abbott Company Details Table 93. Abbott Business Overview Table 94. Abbott Sulfonamides Product Table 95. Abbott Revenue in Sulfonamides Business (2016-2021) & (US$ Million) Table 96. Abbott Recent Development Table 97. GlaxoSmithKline Company Details Table 98. GlaxoSmithKline Business Overview Table 99. GlaxoSmithKline Revenue in Sulfonamides Business (2016-2021) & (US$ Million) Table 100. GlaxoSmithKline Recent Development Table 101. Boehringer Ingelheim Company Details Table 102. Boehringer Ingelheim Business Overview Table 103. Boehringer Ingelheim Sulfonamides Product Table 104. Boehringer Ingelheim Revenue in Sulfonamides Business (2016-2021) & (US$ Million) Table 105. Boehringer Ingelheim Recent Development Table 106. Research Programs/Design for This Report Table 107. Key Data Information from Secondary Sources Table 108. Key Data Information from Primary Sources List of Figures Figure 1. Global Sulfonamides Market Share by Type: 2020 VS 2027 Figure 2. Intestinal Absorption Features Figure 3. Intestinal Tract Difficult to Absorb Features Figure 4. External Use Features Figure 5. Global Sulfonamides Market Share by Application: 2020 VS 2027 Figure 6. Systemic Infection Case Studies Figure 7. Intestinal Infection Case Studies Figure 8. Burn Infection Case Studies Figure 9. Other Infections Case Studies Figure 10. Sulfonamides Report Years Considered Figure 11. Global Sulfonamides Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Sulfonamides Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Sulfonamides Market Share by Regions: 2020 VS 2027 Figure 14. Global Sulfonamides Market Share by Regions (2022-2027) Figure 15. Global Sulfonamides Market Share by Players in 2020 Figure 16. Global Top Sulfonamides Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sulfonamides as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Sulfonamides Revenue in 2020 Figure 18. Global Sulfonamides Revenue Market Share by Type (2016-2021) Figure 19. Global Sulfonamides Revenue Market Share by Type (2022-2027) Figure 20. North America Sulfonamides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Sulfonamides Market Share by Type (2016-2027) Figure 22. North America Sulfonamides Market Share by Application (2016-2027) Figure 23. North America Sulfonamides Market Share by Country (2016-2027) Figure 24. United States Sulfonamides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Sulfonamides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Sulfonamides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Sulfonamides Market Share by Type (2016-2027) Figure 28. Europe Sulfonamides Market Share by Application (2016-2027) Figure 29. Europe Sulfonamides Market Share by Country (2016-2027) Figure 30. Germany Sulfonamides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Sulfonamides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Sulfonamides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Sulfonamides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Sulfonamides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Sulfonamides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Sulfonamides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Sulfonamides Market Share by Type (2016-2027) Figure 38. Asia-Pacific Sulfonamides Market Share by Application (2016-2027) Figure 39. Asia-Pacific Sulfonamides Market Share by Region (2016-2027) Figure 40. China Sulfonamides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Sulfonamides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Sulfonamides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Sulfonamides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Sulfonamides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Sulfonamides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Sulfonamides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Sulfonamides Market Share by Type (2016-2027) Figure 48. Latin America Sulfonamides Market Share by Application (2016-2027) Figure 49. Latin America Sulfonamides Market Share by Country (2016-2027) Figure 50. Mexico Sulfonamides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Sulfonamides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Sulfonamides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Sulfonamides Market Share by Type (2016-2027) Figure 54. Middle East & Africa Sulfonamides Market Share by Application (2016-2027) Figure 55. Middle East & Africa Sulfonamides Market Share by Country (2016-2027) Figure 56. Turkey Sulfonamides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Sulfonamides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Sulfonamides Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Pfizer Revenue Growth Rate in Sulfonamides Business (2016-2021) Figure 60. Sanofi Revenue Growth Rate in Sulfonamides Business (2016-2021) Figure 61. Roche Revenue Growth Rate in Sulfonamides Business (2016-2021) Figure 62. Mylan Revenue Growth Rate in Sulfonamides Business (2016-2021) Figure 63. Teva Revenue Growth Rate in Sulfonamides Business (2016-2021) Figure 64. Bayer Revenue Growth Rate in Sulfonamides Business (2016-2021) Figure 65. Abbott Revenue Growth Rate in Sulfonamides Business (2016-2021) Figure 66. GlaxoSmithKline Revenue Growth Rate in Sulfonamides Business (2016-2021) Figure 67. Boehringer Ingelheim Revenue Growth Rate in Sulfonamides Business (2016-2021) Figure 68. Bottom-up and Top-down Approaches for This Report Figure 69. Data Triangulation Figure 70. Key Executives Interviewed

Pfizer Sanofi Roche Mylan Teva Bayer Abbott GlaxoSmithKline Boehringer Ingelheim